The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Chutko L.S.

N. Bekhtereva Institute of Human Brain Russian Academy of Sciences

Surushkina S.Yu.

N. Bekhtereva Institute of Human Brain Russian Academy of Sciences

Asthenic disorders. History and modernity

Authors:

Chutko L.S., Surushkina S.Yu.

More about the authors

Read: 20869 times


To cite this article:

Chutko LS, Surushkina SYu. Asthenic disorders. History and modernity. S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(6):131‑136. (In Russ.)
https://doi.org/10.17116/jnevro2020120061131

Recommended articles:
Cogi­tum in the treatment of mental diso­rders in childhood. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(10-2):88-95
Search for risk factors for slowed intra-atrial conduction in patients with schi­zophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(11):111-116
Study of the role of inte­rleukin-1β in blood serum in patients with acne. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):421-424
Endo­metriosis-associated infe­rtility and the effi­cacy of dienogest. Russian Journal of Human Reproduction. 2025;(5):58-63

References:

  1. Aleksandrovskii YuA. Pogranichnye psikhicheskie rasstroistva. M. 2000. (In Russ).
  2. Bamdas BS. Astenicheskie sostoyaniya. M. 1961. (In Russ).
  3. Beard GM. Neurasthenia, or Nervous Exhaustion. Boston Med Surg J. 1869;80:217-222.  https://doi.org/10.1056/nejm186904290801301
  4. Belitskii Yu. Nevrasteniya. Ee sushchnost’, prichiny, simptomy, vidy i lechenie. SPb. 1906. (In Russ).
  5. Kennaway J. Stimulating Music: The Pleasures and Dangers of «Electric Music», 1750—1900. Configurations. 2011;19(2):191-211.  https://doi.org/10.1353/con.2011.0018
  6. Price RK, North CS, Wessely S, Fraser VJ. Estimating the prevalence of chronic fatigue syndrome and associated symptoms in the community. Public Health Rep. 1992;107(5):514-522. 
  7. Hickie I, Da Venport T, Issakidis C, Andrews G. Neurasthenia: prevalence, disability and health care characteristics in the Australian community. British Journal of Psychiatry. 2002;181:56-61.  https://doi.org/10.1192/bjp.181.1.56
  8. Skapinakis P, Lewis G, Mavreas V. Temporal relation between unexplained fatigue and depression: longitudinal data from an international study in primary care. Psychosom Med. 2004;66(3):330-335.  https://doi.org/10.1097/01.psy.0000124757.10167.b1
  9. Watanabe N, Stewart R, Jenkins R, Bhugra DK, Furukawa TA. The epidemiology of chronic fatigue, physical illness, and symptoms of common mental disorders: a cross-sectional survey from the second British National Survey of Psychiatric Morbidity. J Psychosom Res. 2008;64(4):357-362.  https://doi.org/10.1016/j.jpsychores.2007.12.003
  10. Akarachkova ES. Chronic fatigue syndrome and an approach to its treatment. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2010;1(2):48-54. (In Russ).
  11. Kreindler A. Astenicheskii nevroz. Per. s rum. Bukharest. 1963. (In Russ).
  12. Polozhii BS. Psikhicheskoe zdorov’e i sotsial’noe sostoyanie obshchestva. Sotsiokul’tural’nye problemy sovremennoi psikhiatrii. Materialy VIII nauchnyh Kerbikovskih chtenij. M. 1994;88-94. (In Russ).
  13. Myasishchev VN. Lichnost’ i nevrozy. Monografiya. Izdatel’stvo Leningradskogo Universiteta; 1960. (In Russ).
  14. Svyadoshch AM. Nevrozy. Ruk-vo dlya vrachei. SPb.: Piter; 1997. (In Russ).
  15. Stubhaug B, Tveito TH, Eriksen HR, Ursin H. Neurasthenia, subjective health complaints and sensitization. Psychoneuroendocrinology. 2005;30(10):1003-1009. https://doi.org/10.1016/j.psyneuen.2005.04.011
  16. Smulevich AB. Pogranichnye psikhicheskie narusheniya. Rukovodstvo po psikhiatrii. M. 1999. (In Russ).
  17. Vasil’eva AV, Karavaeva TA, Poltorak SV. Lingering forms of neurotic disorders: clinical-psychopathological aspects and therapy issues. Obozrenie Psikhiatrii i Meditsinskoi Psikhologii. 2012;4:81-87 (In Russ).
  18. Afari N, Buchwald D. Chronic fatigue syndrome: a review. Am J Psychiatry. 2003;160:221-236.  https://doi.org/10.1176/appi.ajp.160.2.221
  19. Bested AC, Marshall LM. Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians. Rev Environ Health. 2015;30(4):223-249.  https://doi.org/10.1515/reveh-2015-0026
  20. White PD. What causes chronic fatigue syndrome? BMJ. 2004;329(7472):928-929.  https://doi.org/10.1136/bmj.329.7472.928
  21. Underhill RA. Myalgic encephalomyelitis, chronic fatigue syndrome: An infectious disease. Med Hypotheses. 2015;85(6):765-773.  https://doi.org/10.1016/j.mehy.2015.10.011
  22. Van Houdenhove B, Kempke S, Luyten P. Psychiatric Aspects of Chronic Fatigue Syndrome and Fibromyalgia. Current Psychiatry. 2010;12(3):208-214.  https://doi.org/10.1007/s11920-010-0105-y
  23. Rollnik JD. Chronic Fatigue Syndrome: A Critical Review. Fortschr Neurol Psychiatr. 2017;85(2):79-85.  https://doi.org/10.1055/s-0042-121259
  24. Słomko J, Newton JL, Kujawski S, Tafil-Klawe M, Klawe J, Staines D, Marshall-Gradisnik S, Zalewski P. Prevalence and characteristics of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) in Poland: a cross-sectional study. BMJ Open. 2019;9(3):e023955. https://doi.org/10.1136/bmjopen-2018-023955
  25. Johnston SC, Staines DR, Marshall-Gradisnik SM. Epidemiological characteristics of chronic fatigue syndrome/myalgic encephalomyelitis in Australian patients. Clin Epidemiol. 2016;8:97-107.  https://doi.org/10.2147/CLEP.S96797
  26. Owe JF, Næss H, Gjerde IO, Bødtker JE, Tysnes OB. Investigation of suspected chronic fatigue syndrome/myalgic encephalopathy. Tidsskr Nor Laegeforen. 2016;136(3):227-232.  https://doi.org/10.4045/tidsskr.15.0229
  27. Wessely S. Chronic fatigue syndrome. British Journal of Psychiatry. 1990;157(3):447-448.  https://doi.org/10.1192/bjp.157.3.447
  28. Overholser J, Beale E. Neurasthenia. The Journal of Nervous and Mental Disease. 2019;207(9):731-739.  https://doi.org/10.1097/nmd.0000000000000943
  29. Galvez-Sánchez CM, Duschek S, Reyes Del Paso GA. Psychological impact of fibromyalgia: current perspectives. Psychol Res Behav Manag. 2019;12:117-127.  https://doi.org/10.2147/PRBM.S178240
  30. Fukuda K. The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study. Annals of Internal Medicine. 1994;121(12):953.  https://doi.org/10.7326/0003-4819-121-12-199412150-00009
  31. Fedin AI, Solov’eva ÉIu, Mironova OP, Fedotova AV. Treatment of asthenic syndrome in patients with chronic brain ischemia: results of the non-interventional observational program TRIUMPH. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2014;114(12):104-111. (In Russ). https://doi.org/10.17116/jnevro2014114121104-111
  32. Kadykov AS, Shakhparonova NV, Kashina EM. Astenic conditions in the clinic of vascular diseases of the brain and the possibility of their correction. Nervnye bolezni. 2012;1:24-28. (In Russ).
  33. Bogousslavsky J. William Feinberg Lecture 2002: emotions, mood and behavior after stroke. Stroke. 2003;34:1046-1050. https://doi.org/10.1161/01.str.0000061887.33505.b9
  34. Acciarresi M, Bogousslavsky J, Paciaroni M. Post-Stroke Fatigue: Epidemiology, Clinical Characteristics and Treatment. European Neurology. 2014;72(5-6):255-261.  https://doi.org/10.1159/000363763
  35. van Rooij FG, Plaizier NO, Vermeer SE, Góraj BM, Koudstaal PJ, Richard E, de Leeuw FE, Kessels RPC, van Dijk EJ. Subjective Cognitive Impairment, Depressive Symptoms, and Fatigue after a TIA or Transient Neurological Attack: A Prospective Study. Behav Neurol. 2017;5181024. https://doi.org/10.1155/2017/5181024
  36. Solov’eva SL, Uspenskii YuP, Fominykh YuA. Ponyatie astenii v klinike vnutrennikh boleznei. Astenicheskie rasstroistva v terapevticheskoi praktike. Rukovodstvo po diagnostike i lecheniyu. Pod. red. Shabrova A.V., Solov’evoi S.L. SPb. 2010. (In Russ).
  37. Bushnik T, Englander J, Wright J. Patterns of fatigue and its correlates over the first 2 years after traumatic brain injury. J Head Trauma Rehabil. 2008;23(1):25-32.  https://doi.org/10.1097/01.htr.0000308718.88214.bb
  38. Cantor JB, Ashman T, Gordon W, Ginsberg A, Engmann C, Egan M, Spielman L, Dijkers M, Flanagan S. Fatigue after traumatic brain injury and its impact on participation and quality of life. J Head Trauma Rehabil. 2008;23(1):41-51.  https://doi.org/10.1097/01.htr.0000308720.70288.af
  39. Wylie GR, Dobryakova E, DeLuca J, Chiaravalloti N, Essad K, Genova H. Cognitive fatigue in individuals with traumatic brain injury is associated with caudate activation. Sci Rep. 2017;7(1):89-73.  https://doi.org/10.1038/s41598-017-08846-6
  40. Beaulieu-Bonneau S, Morin CM. Sleepiness and fatigue following traumatic brain injury. Sleep Med. 2012;13(6):598-605.  https://doi.org/10.1016/j.sleep.2012.02.010
  41. Ponsford JL, Hsieh M. Psychological Interventions for Emotional and Behavioral Problems Following Traumatic Brain Injury. In: Zasler N.D., Katz D.I. eds Brain Injury Medicine. Principles and Practice, 2nd Edition; 2012. https://doi.org/10.1891/9781617050572.0064
  42. Boni J, Maugeri A, Zingali G, Ramelli L, Gherardi S. Steady-state pharmacokinetics of idebenone in healthy volunteers. Archives of Gerontology and Geriatrics. 1992;15:3:197-205.  https://doi.org/10.1016/0167-4943(92)90055-9
  43. Rachin AP, Averchenkova AA. Idebenone (noben) — from theory to practice. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2011;111(5):81-84. (In Russ).
  44. Damulin IV. The use of idebenone (noben) in neurological practice. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2006;106:66-71. (In Russ).
  45. Takuma K, Yoshida T, Lee E, Mori K, Kishi T, Baba A, Matsuda T. CV-2619 protects cultured astrocytes against reperfusion injury via nerve growth factor production. Eur J Pharmacol. 2000;406:333-339.  https://doi.org/10.1016/s0014-2999(00)00701-9
  46. Cardoso SM, Pereira C, Oliveira CR. The protective effect of vitamin E, idebenone and reduced glutathione on free radical mediated injury in rat brain synaptosomes. Biochem Biophys Res Commun. 1998;246:703-710.  https://doi.org/10.1006/bbrc.1998.8563
  47. Marigliano V, Abate G, Barbagallo-Sangiorgi G, Bartorelli L, Capurso A, Cucinotta D, Cuzzupoli M, Senin U, Tammaro AE, Fioravanti M. Randomized, double-blind, placebo controlled, multicentre study of idebenone in patients suffering from multi-infarct dementia. Arch Gerontol Geriat. 1992;15:239-248.  https://doi.org/10.1016/0167-4943(92)90059-d
  48. Bergamasco B, Villardita C, Coppi R. Idebenone in the treatment of multi-infarct dementia: a randomised, double-blind, placebo controlled multicentre trial. Arch Gerontol Geriatr. 1992;15:271-278.  https://doi.org/10.1016/0167-4943(92)90062-9
  49. Muzychenko AP, Krasnoslobodtseva LA. Deistvie Nobena pri organicheskom emotsional’no-labil’nom (astenicheskom) rasstroistve: klinicheskie i neirofiziologicheskie aspekty. Klinicheskaya farmakologiya. 2008;1:2-5. (In Russ).
  50. Voronkova KV, Meleshkov MN. Noben (idebenone) in the treatment of dementia and memory impairment without dementia. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2008;108:4:27-32. (In Russ).
  51. Boiko AN, Lebedeva AV, Shchukin IA, Soldatov MA, Petrov SV, Khozova AA, Ismailov AM, Shikhkerimov RK. Emotsional’nye rasstroistva i kachestvo zhizni u patsientov s postinsul’tnoi asteniei. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2013;11:27-33. (In Russ).
  52. Slizkova YuB. Experience of application of noben in the treatment of post-communication syndrome in patients after a light cranio-brain injury. Nervnye Bolezni. 2007;2:22-26. (In Russ).

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.